Physician profile
Jane Ahn
NPI 1205154366
$1,869.17
in general payments reported to CMS, 2019-2025
29 companies · $54.22 in 2025
The $54.22 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $153 · 2021: $150 · 2022: $493 · 2023: $389 · 2024: $161 · 2025: $54.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $604.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $404.52 | 2019-2025 | Liletta, Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $279.81 | 2019-2024 | |
| Caldera Medical, INC | $160.00 | 2019 | |
| Mayne Pharma Commercial LLC | $118.63 | 2022-2023 | |
| Myovant Sciences INC. | $102.95 | 2022 | |
| Sumitomo Pharma America, INC. | $90.71 | 2023 | Myfembree |
| Organon LLC | $84.77 | 2021-2024 | Nexplanon |
| Therapeuticsmd, INC. | $62.74 | 2019-2022 | |
| Hologic Sales and Service, LLC | $55.75 | 2019-2024 | Aptima |
| Merck Sharp & Dohme LLC | $47.37 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $43.71 | 2019 | |
| Daiichi Sankyo INC. | $37.87 | 2019-2020 | |
| Evofem Biosciences, INC. | $32.84 | 2022 | |
| Biogen, INC. | $29.14 | 2025 | Zurzuvae |
| Lupin INC. | $28.51 | 2020-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $28.23 | 2020-2022 | |
| Avion Pharmaceuticals | $28.14 | 2022-2023 | Balcoltra |
| Coopersurgical, INC. | $27.84 | 2019-2022 | |
| Allergan, INC. | $26.75 | 2019 | |
| Shield Therapeutics INC | $26.63 | 2024 | |
| Channel Medsystems, INC. | $24.24 | 2021 | |
| Aspira Women'S Health INC | $21.24 | 2024 | Ova1 |
| Boston Scientific Corporation | $19.81 | 2022 | |
| Astellas Pharma US INC | $19.25 | 2024 | Veozah |
| Smith+Nephew, INC. | $16.56 | 2024 | Pico 7, Renasys Touch, Pico 14 |
| Gynesonics, INC. | $14.32 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exeltis, USA INC. | $12.99 | 2023 | Slynd |
| Alydia Health | $12.49 | 2021 | |
| Duchesnay USA Incorporated | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Ahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.